• Magnetic Stimulation Downregulates GABRE to Reverse SCZ Beha

  2026-06-16

  The referenced study introduces a combined magnetic stimulation system (c-MSST) targeting the left prelimbic cortex to selectively downregulate the GABAA receptor ε subunit (GABRE), resulting in reversal of schizophrenia-like behaviors in mice. This work elucidates a region- and subunit-specific neuromodulatory mechanism, offering new molecular avenues for therapeutic intervention in schizophrenia.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-06-16

  This study uncovers a pyroptosis-independent mechanism by which Gasdermin C (GSDMC) enhances stemness and immune evasion in pancreatic ductal adenocarcinoma (PDAC). The findings identify GSDMC as a key nuclear regulator of cancer progression and immune suppression, suggesting new therapeutic targets for improving immunotherapy responses.

• HotStart 2X Green qPCR Master Mix: Precision in Gene Quantif

  2026-06-15

  The HotStart™ 2X Green qPCR Master Mix redefines SYBR Green qPCR with high specificity, streamlined workflows, and robust reproducibility. Optimal for gene expression analysis and biomarker validation, this APExBIO reagent empowers researchers to decode molecular signatures in challenging samples.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-06-15

  The Hoechst 33342/PI Double Staining Kit provides a standardized approach for rapid, fluorescence-based discrimination of apoptotic, necrotic, and viable cells in cultured cell assays. This kit is intended exclusively for basic research workflows requiring assessment of chromatin condensation and membrane integrity, and should not be used for diagnostic or clinical applications.

• SAR131675: Precision VEGFR-3 Inhibitor for Tumor and Vascula

  2026-06-14

  SAR131675 stands out as a potent, highly selective VEGFR-3 inhibitor for dissecting lymphangiogenesis and angiogenesis in cancer and fibrosis models. This guide distills effective workflow strategies, troubleshooting insights, and protocol parameters to maximize SAR131675's impact in preclinical studies.

• Annexin V-FITC/7-AAD Apoptosis Kit: Practical Use Guide

  2026-06-13

  The Annexin V-FITC/7-AAD Apoptosis Kit offers a rapid, sensitive method for distinguishing apoptotic from necrotic cells in established cell viability and cytotoxicity assays. It is optimized for use with flow cytometry or fluorescence microscopy and is not intended for detailed mechanistic pathway studies. Researchers benefit from clear protocols and defined storage conditions, while avoiding unsupported applications.

• CKI 7 dihydrochloride: Reliable CK1 Inhibition in Cell Assay

  2026-06-12

  This article provides an evidence-based, scenario-driven guide to deploying CKI 7 dihydrochloride (SKU B4936) as a selective Casein kinase 1 inhibitor for cell viability and signaling pathway research. Drawing on current literature and best practices, we address experimental design, optimization, and product reliability—highlighting why CKI 7 dihydrochloride is a trusted solution for reproducible and interpretable data.

• Cabozantinib (XL184): Multiscale Remodeling and RTK Inhibiti

  2026-06-12

  Explore the advanced mechanisms by which Cabozantinib (XL184) disrupts receptor tyrosine kinase signaling and induces phosphoproteomic remodeling in cancer models. This in-depth analysis reveals actionable insights for designing robust antiangiogenic and adaptation studies.

• Calpain Inhibition: Mechanistic Leverage for Translational O

  2026-06-11

  This thought-leadership article explores how Calpain Inhibitor II, ALLM empowers translational oncology by targeting calpain and cathepsin pathways. Drawing from recent findings on lncRNA-mediated FAK regulation in triple negative breast cancer, we bridge mechanistic insight with strategic guidance for apoptosis and protease inhibition assays, especially in leukemia and lymphoma research. Practical protocol recommendations and a critical outlook position APExBIO’s solution as a catalyst for innovative cancer research.

• Translational Protease Inhibition: From Mechanism to High-Im

  2026-06-11

  This thought-leadership article illuminates the strategic, mechanistic, and translational landscape of protease inhibition, offering researchers actionable insights and evidence-based guidance. By synthesizing state-of-the-art findings—including advances in HIV-1 protease autoprocessing assays and cross-domain research in cancer and infectious disease—the article positions the DiscoveryProbe™ Protease Inhibitor Library as a uniquely powerful resource. It distinguishes itself from standard product literature by bridging biological rationale, workflow validation, and the competitive context for next-generation translational research.

• Bufalin Targets STK33 in Triple-Negative Breast Cancer Model

  2026-06-10

  This study identifies Serine/Threonine Kinase 33 (STK33) as a direct molecular target of the cardiotonic steroid Bufalin in triple-negative breast cancer (TNBC). The findings clarify Bufalin's mechanism as a selective degrader of STK33, providing a new therapeutic angle for TNBC and advancing precision research strategies.

• Protease Inhibitors Block Light-Induced Stomatal Opening in

  2026-06-10

  Wang et al. (2021) developed a chemical screening approach to identify protease inhibitors that disrupt blue light-induced stomatal opening in Commelina benghalensis. Their findings reveal new regulatory mechanisms in guard cell signaling, with implications for plant physiology and chemical biology.

• FAM83A Regulates Mitochondrial Integrity in White Adipocytes

  2026-06-09

  The reference study uncovers a novel physiological role for FAM83A in maintaining mitochondrial function and promoting white adipocyte differentiation via its interaction with casein kinase 1. Utilizing targeted gene knockdown in vivo and in vitro, the research demonstrates that FAM83A is critical for adipogenesis and metabolic homeostasis, offering new insights for obesity and metabolic disease models.

• Mapping Subcellular RNA-Binding Proteins via Functional Prox

  2026-06-09

  This study introduces APEX-PS, a method combining peroxidase-catalyzed proximity biotinylation with phase separation to map subcellular RNA-binding proteins (RBPs) with high spatial and temporal resolution. The approach reveals novel insights into mitochondrial mRNA retention during stress recovery, offering a valuable blueprint for spatially resolved proteomics.

• Telmisartan: Mechanistic Leverage in Cardiac Hypertrophy Mod

  2026-06-08

  This article provides a thought-leadership perspective on leveraging Telmisartan as an angiotensin II receptor antagonist in translational cardiovascular research. Integrating mechanistic insights from recent discoveries around the RIP3/CaMKII axis and necroptosis in cardiac hypertrophy, it offers strategic guidance for experimental design, discusses the evolving competitive landscape, and positions APExBIO's Telmisartan as a precision tool for dissecting hypertension-driven cardiac remodeling.

16079 records 1/1072 page Next 12345 下5页 Last page